Clinical Trials
2 trialsNCT07018427 2025-06-12
Real-world Study of Sacituzumab Govitecan Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer
Peking University Cancer Hospital & Institute
Active not recruiting
NCT04486911 2022-08-02
Pyrotinib Maleate, CDK4/6 Inhibitor and Letrozole in Combination for Stage II-III TPBC: a Phase II Trial
Shengjing Hospital
Phase 2 Active not recruiting